United States · FDA National Drug Code directory

Liothyronine Sodium

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 68788-7269_cb7904ed-91d9-47c1-8841-5cea1d5c9ed0
Product NDC: 68788-7269
Form: TABLET
Composition / generic term: Liothyronine Sodium
Labeler: Preferred Pharmaceuticals Inc.
Marketing category: ANDA
Marketing start / end (source format): 20190111
Source listing expiry: 20271231

Source-listed ingredients

LIOTHYRONINE SODIUM — 5 ug/1

These values do not establish equivalence or a dose recommendation.

Packages

30 TABLET in 1 BOTTLE (68788-7269-3) · 68788-7269-3
60 TABLET in 1 BOTTLE (68788-7269-6) · 68788-7269-6
90 TABLET in 1 BOTTLE (68788-7269-9) · 68788-7269-9

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →